A cancer therapy resistant to resistance

被引:294
作者
Kerbel, RS
机构
[1] the University of Toronto,
[2] and in the Cancer Research Program,undefined
[3] Sunnybrook Health Science Centre,undefined
关键词
D O I
10.1038/36978
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The relentless growth of tumours depends on a good blood supply, and thus on subverting host mechanisms for making blood vessels. Attack on that process provides a promising route for treating cancer, but one that may take some years to reach clinical fruition.
引用
收藏
页码:335 / 336
页数:2
相关论文
共 21 条
[1]   VASCULAR ENDOTHELIAL GROWTH-FACTOR ACTS AS A SURVIVAL FACTOR FOR NEWLY FORMED RETINAL-VESSELS AND HAS IMPLICATIONS FOR RETINOPATHY OF PREMATURITY [J].
ALON, T ;
HEMO, I ;
ITIN, A ;
PEER, J ;
STONE, J ;
KESHET, E .
NATURE MEDICINE, 1995, 1 (10) :1024-1028
[2]   Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal [J].
Benjamin, LE ;
Keshet, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (16) :8761-8766
[3]   Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].
Boehm, T ;
Folkman, J ;
Browder, T ;
OReilly, MS .
NATURE, 1997, 390 (6658) :404-407
[4]   How tumors become angiogenic [J].
Bouck, N ;
Stellmach, V ;
Hsu, SC .
ADVANCES IN CANCER RESEARCH, VOL 69, 1996, 69 :135-174
[5]   REDUCTION BY GRANULOCYTE COLONY-STIMULATING FACTOR OF FEVER AND NEUTROPENIA INDUCED BY CHEMOTHERAPY IN PATIENTS WITH SMALL-CELL LUNG-CANCER [J].
CRAWFORD, J ;
OZER, H ;
STOLLER, R ;
JOHNSON, D ;
LYMAN, G ;
TABBARA, I ;
KRIS, M ;
GROUS, J ;
PICOZZI, V ;
RAUSCH, G ;
SMITH, R ;
GRADISHAR, W ;
YAHANDA, A ;
VINCENT, M ;
STEWART, M ;
GLASPY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (03) :164-170
[6]  
FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
[7]   Tumor angiogenesis and tissue factor [J].
Folkman, J .
NATURE MEDICINE, 1996, 2 (02) :167-168
[8]   Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis [J].
Hanahan, D ;
Folkman, J .
CELL, 1996, 86 (03) :353-364
[9]   DELIVERY OF NOVEL THERAPEUTIC AGENTS IN TUMORS - PHYSIOLOGICAL BARRIERS AND STRATEGIES [J].
JAIN, RK .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (08) :570-576
[10]   INHIBITION OF TUMOR ANGIOGENESIS AS A STRATEGY TO CIRCUMVENT ACQUIRED-RESISTANCE TO ANTICANCER THERAPEUTIC AGENTS [J].
KERBEL, RS .
BIOESSAYS, 1991, 13 (01) :31-36